Possible Prognostic and Therapeutic Significance of c-Kit Expression, Mast Cell Count and Microvessel Density in Renal Cell Carcinoma

C-Kit and Its Ligand Stem Cell Factor: Potential Contribution to Prostate Cancer Bone Metastasis

(2015) Christoph Wiesner et al.   NEOPLASIA

C-Kit Expression, Angiogenesis, and Grading in Canine Mast Cell Tumour: A Unique Model to Study C-Kit Driven Human Malignancies

(2014) Rosa Patruno et al.   Biomed Research International

Epidemiology and Staging of Renal Cell Carcinoma

(2014) Carole Ridge et al.   SEMINARS IN INTERVENTIONAL RADIOLOGY

The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia

(2013) John R. Srigley et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Masitinib (AB1010), from canine tumor model to human clinical development: Where we are?

(2013) Ilaria Marech et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin

(2013) F. Stephen Hodi et al.   JOURNAL OF CLINICAL ONCOLOGY

Prolonged exposure to tyrosine kinase inhibitors or early use of everolimus in metastatic renal cell carcinoma: are the two options alike?

(2013) Nicola Calvani et al.   MEDICAL ONCOLOGY

Mast Cell Positivity to Tryptase Correlates with Metastatic Lymph Nodes in Gastrointestinal Cancer Patients Treated Surgically

(2013) Michele Ammendola et al.   ONCOLOGY

Searching for Hif1-α interacting proteins in renal cell carcinoma

(2012) V. Medina Villaamil et al.   Clinical & Translational Oncology

Editorial [ Hot Topic: Targeting Tumor Angiogenesis: An Update (Guest Editor: Girolamo Ranieri)]

(2012) Girolamo Ranieri   CURRENT MEDICINAL CHEMISTRY

Tumor endothelial markers as a target in cancer

(2012) Domenico Ribatti et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer

(2012) Sakari Vanharanta et al.   NATURE MEDICINE

c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin–ATP-binding cassette G2 signaling

(2012) W K Chau et al.   ONCOGENE

The VHL/HIF axis in clear cell renal carcinoma

(2012) Chuan Shen et al.   SEMINARS IN CANCER BIOLOGY

The Roles of VHL-Dependent Ubiquitination in Signaling and Cancer

(2012) Qing Zhang et al.   Frontiers in Oncology

Distinct classes of c-Kit-activating mutations differ in their ability to promote RUNX1-ETO-associated acute myeloid leukemia

(2011) H. J. Nick et al.   BLOOD

The Epidemiology of Renal Cell Carcinoma

(2011) Börje Ljungberg et al.   EUROPEAN UROLOGY

Tissue remodelling in breast cancer: human mast cell tryptase as an initiator of myofibroblast differentiation

(2011) Anita Mangia et al.   HISTOPATHOLOGY

Tryptase-positive mast cells and CD8-positive T cells in human endometrial cancer

(2011) Domenico Ribatti et al.   PATHOLOGY INTERNATIONAL

Mast cells and angiogenesis in gastric carcinoma

(2010) Domenico Ribatti et al.   INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Mast cell phenotypes and microvessels in non–small cell lung cancer and its prognostic significance

(2009) María José Carlini et al.   HUMAN PATHOLOGY

Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients

(2009) Ranieri   INTERNATIONAL JOURNAL OF ONCOLOGY

The lack of correlation between mast cells and microvessel density with pathologic feature of renal cell carcinoma

(2009) Mohammad Ghassem Mohseni et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Mast Cells Contribute to Vasculogenic Mimicry in Multiple Myeloma

(2008) Beatrice Nico et al.   STEM CELLS AND DEVELOPMENT

Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer

(2007) Maya Gulubova et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY